Dermira Commences Follow-on Public Offering of Common Stock
04 août 2015 16h01 HE
|
Dermira, Inc.
MENLO PARK, Calif., Aug. 4, 2015 (GLOBE NEWSWIRE) -- Dermira, Inc. (NASDAQ:DERM), a specialty biopharmaceutical company focused on bringing innovative and differentiated products to dermatologists and...
Dermira Doses First Patients in DRM04 Phase 3 Program in Axillary Hyperhidrosis
03 août 2015 07h30 HE
|
Dermira, Inc.
Two Identical Studies to Enroll a Combined Total of 660 Patients
Topline Phase 3 Data Expected in the Second Half of 2016
Represents Dermira's Second Product Candidate in Phase 3...
Dermira's Phase 2a DRM01 Acne Trial Data Presented at the World Congress of Dermatology Meeting
09 juin 2015 07h30 HE
|
Dermira, Inc.
MENLO PARK, Calif., June 9, 2015 (GLOBE NEWSWIRE) -- Dermira, Inc. (Nasdaq:DERM), a specialty biopharmaceutical company focused on bringing innovative and differentiated products to dermatologists and...
Dermira Announces Poster Presentation on DRM01 in Acne at World Congress of Dermatology
02 juin 2015 07h30 HE
|
Dermira, Inc.
MENLO PARK, Calif., June 2, 2015 (GLOBE NEWSWIRE) -- Dermira, Inc. (Nasdaq:DERM), a specialty biopharmaceutical company focused on bringing innovative and differentiated products to dermatologists and...
Dermira to Present at Jefferies 2015 Global Healthcare Conference
28 mai 2015 07h30 HE
|
Dermira, Inc.
MENLO PARK, Calif., May 28, 2015 (GLOBE NEWSWIRE) -- Dermira, Inc. (Nasdaq:DERM), a specialty biopharmaceutical company focused on bringing innovative and differentiated products to dermatologists and...
Dermira Reports First Quarter 2015 Financial Results and Provides Corporate Update
12 mai 2015 16h13 HE
|
Dermira, Inc.
MENLO PARK, Calif., May 12, 2015 (GLOBE NEWSWIRE) -- Dermira, Inc. (Nasdaq:DERM), a specialty biopharmaceutical company focused on bringing innovative and differentiated products to dermatologists and...
Dermira Doses First Patient in DRM01 Phase 2b Acne Trial
09 avr. 2015 07h30 HE
|
Dermira, Inc.
MENLO PARK, Calif., April 9, 2015 (GLOBE NEWSWIRE) -- Dermira, Inc. (Nasdaq:DERM), a specialty biopharmaceutical company focused on bringing innovative and differentiated products to dermatologists...
Dermira to Present at the 14th Annual Needham Healthcare Conference
08 avr. 2015 07h30 HE
|
Dermira, Inc.
MENLO PARK, Calif., April 8, 2015 (GLOBE NEWSWIRE) -- Dermira, Inc. (Nasdaq:DERM), a specialty biopharmaceutical company focused on bringing innovative and differentiated products to dermatologists...
Dermira Reports Fourth Quarter and Full Year 2014 Financial Results and Provides Corporate Update
25 mars 2015 16h09 HE
|
Dermira, Inc.
DRM01 Phase 2b Trial in Acne to Start April 2015
Conference Call Today at 4:30 p.m. Eastern Time
MENLO PARK, Calif., March 25, 2015 (GLOBE NEWSWIRE) -- Dermira, Inc. (Nasdaq:DERM), a specialty...
Dermira to Report Fourth Quarter and Full Year 2014 Financial Results
18 mars 2015 16h05 HE
|
Dermira, Inc.
MENLO PARK, Calif., March 18, 2015 (GLOBE NEWSWIRE) -- Dermira, Inc. (Nasdaq:DERM), a specialty biopharmaceutical company focused on bringing innovative and differentiated dermatology products to...